Literature DB >> 2340164

Inhibition of nitric oxide synthesis potentiates hypoxic vasoconstriction in isolated rat lungs.

B E Robertson1, J B Warren, P C Nye.   

Abstract

We have investigated the influence of endogenous nitric oxide (NO) on the vascular resistance of isolated rat lungs by inhibiting its synthesis with the false substrate N-monomethyl-L-arginine (L-NMMA). When perfused with blood at constant flow the addition of L-NMMA (10(-3) M) did not affect pulmonary arterial pressure in hyperoxia but did increase the response to hypoxia (PO2 25-35 mmHg) by 2.5 +/- 0.2 fold (mean +/- S.E.M.). The effect of L-NMMA was reversed by 3 x 10(-3) M-L-arginine, the true substrate for NO synthesis. Thus NO is an important pulmonary vasodilator but hypoxic vasoconstriction does not result from a reduction of its background release.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340164     DOI: 10.1113/expphysiol.1990.sp003399

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  5 in total

1.  Vasodilators in pulmonary hypertension.

Authors:  A Peacock
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

Review 2.  Hypoxic pulmonary vasoconstriction: mechanisms of oxygen-sensing.

Authors:  A Mark Evans; D Grahame Hardie; Chris Peers; Amira Mahmoud
Journal:  Curr Opin Anaesthesiol       Date:  2011-02       Impact factor: 2.706

3.  Nitric oxide and pulmonary hypertension.

Authors:  Ji-Yeon Sim
Journal:  Korean J Anesthesiol       Date:  2010-01-31

4.  Changes in functional and histological distributions of nitric oxide synthase caused by chronic hypoxia in rat small pulmonary arteries.

Authors:  Mikiyasu Shirai; James T Pearson; Akito Shimouchi; Noritoshi Nagaya; Hirotsugu Tsuchimochi; Ishio Ninomiya; Hidezo Mori
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

5.  Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats.

Authors:  G Barer; C Emery; A Stewart; D Bee; P Howard
Journal:  J Physiol       Date:  1993-04       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.